Missense mutations of the glycine decarboxylase gene (Gldc) are associated clinically with a metabolic disorder, Non‐ketotic hyperglycinemia (NKH) and neural tube defects (NTDs) such as exencephaly. Here, GLDC is linked to glycine encephalopathy.